SCHEMBL20355593

SCHEMBL20355593

O=C(Nc1ccccc1F)c1cnc2ccc(N3CCCC3)nn12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 5/20 0.53
▸ TP53 P04637 2/20 0.51
▸ EPHB3 P54753 1/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ GLA P06280 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ DGAT1 O75907 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14897370 0.87 IRAK4 (0.52) IRAK4TP53EPHB3KMT2AMEN1
SCHEMBL20355596 0.86 IRAK4 (0.53) IRAK4TP53
SCHEMBL14897258 0.80 IRAK4 (0.48) IRAK4KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL21765953 0.79 IRAK4 (0.50) IRAK4TP53NPSR1GAAKMT2A
SCHEMBL14897548 0.79 IRAK4 (0.54) IRAK4L3MBTL1SMN1; SMN2RAB9ADGAT1
SCHEMBL14897367 0.79 IRAK4 (0.51) IRAK4GAAHTTALDH1A1TSHR
SCHEMBL14897368 0.78 IRAK4 (0.46) IRAK4TP53KMT2AMEN1ALDH1A1
SCHEMBL14897737 0.78 IRAK4 (0.49) IRAK4MAPT
SCHEMBL14897256 0.77 IRAK4 (0.46) IRAK4EPHB3KMT2AMEN1HTT
SCHEMBL18654870 0.77 IRAK4 (0.48) IRAK4EPHB3KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180186801-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2018-07-05 — — US disclosed
US-20180186801-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2018-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180186801-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 IRAK4 3168/4885TP53 362/4885EPHB3 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback